Cathy Friedman is a business executive with nearly 40 years of experience across finance, technology, and healthcare. As Executive Venture Partner at GV, she advises the life sciences portfolio and invests across the healthcare continuum. Her interests include adolescent mental health, the full lifespan of women’s health, and more equitable systems for the underserved. Before joining GV in 2021, Cathy spent 15 years on the boards of leading public and private life sciences and technology companies. Recently, in addition to her role as board chair at Grail (acquired by Illumina), she has been an indepe...read more